MHS
REGN icon

M Holdings Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

M Holdings Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-773
Closed -$366K – 416
2021
Q1 		$366K Buy
+773
New +$376K 0.03% 348

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

M Holdings Securities's REGN Position: Q2 2021 in Review

M Holdings Securities sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 773 shares — an estimated $366K sold.

M Holdings Securities first reported a position in REGN in Q1 2021 and held it in 1 quarter. The position peaked at $366K in Q1 2021. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • M Holdings Securities reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • M Holdings Securities sold 773 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $366K.
  • M Holdings Securities first reported a position in Regeneron Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • M Holdings Securities's Regeneron Pharmaceuticals position peaked at $366K in Q1 2021.
  • 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on M Holdings Securities's 13F filing for Q2 2021, filed 19 Aug 2021.